Lynch Thomas J. Jr. - Net Worth and Insider Trading

Lynch Thomas J. Jr. Net Worth

The estimated net worth of Lynch Thomas J. Jr. is at least $537,622 dollars as of 2024-11-13. Lynch Thomas J. Jr. is the EVP & Chief Scientific Officer of Bristol-Myers Squibb Co and owns about 9,251 shares of Bristol-Myers Squibb Co (BMY) stock worth over $537,622. Details can be seen in Lynch Thomas J. Jr.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lynch Thomas J. Jr. has not made any transactions after 2017-12-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Lynch Thomas J. Jr.

To

Lynch Thomas J. Jr. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lynch Thomas J. Jr. owns 3 companies in total, including Bristol-Myers Squibb Co (BMY) , Infinity Pharmaceuticals Inc (INFIQ) , and Foghorn Therapeutics Inc (FHTX) .

Click here to see the complete history of Lynch Thomas J. Jr.’s form 4 insider trades.

Insider Ownership Summary of Lynch Thomas J. Jr.

Ticker Comapny Transaction Date Type of Owner
BMY Bristol-Myers Squibb Co 2017-12-12 director
INFIQ Infinity Pharmaceuticals Inc 2009-10-06 director
FHTX Foghorn Therapeutics Inc 2022-10-27 director

Lynch Thomas J. Jr. Latest Holdings Summary

Lynch Thomas J. Jr. currently owns a total of 1 stock. Lynch Thomas J. Jr. owns 9,251 shares of Bristol-Myers Squibb Co (BMY) as of December 12, 2017, with a value of $537,622.

Latest Holdings of Lynch Thomas J. Jr.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BMY Bristol-Myers Squibb Co 2017-12-12 9,251 58.12 537,622

Holding Weightings of Lynch Thomas J. Jr.


Lynch Thomas J. Jr. Form 4 Trading Tracker

According to the SEC Form 4 filings, Lynch Thomas J. Jr. has made a total of 0 transactions in Bristol-Myers Squibb Co (BMY) over the past 5 years. The most-recent trade in Bristol-Myers Squibb Co is the sale of 5,300 shares on December 12, 2017, which brought Lynch Thomas J. Jr. around $335,172.

Insider Trading History of Lynch Thomas J. Jr.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Lynch Thomas J. Jr. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Lynch Thomas J. Jr. Ownership Network

Ownership Network List of Lynch Thomas J. Jr.

No Data

Ownership Network Relation of Lynch Thomas J. Jr.

Insider Network Chart

Lynch Thomas J. Jr. Owned Company Details

What does Bristol-Myers Squibb Co do?

Who are the key executives at Bristol-Myers Squibb Co?

Lynch Thomas J. Jr. is the director of Bristol-Myers Squibb Co. Other key executives at Bristol-Myers Squibb Co include Chief Medical Offr. & Drug Dev. Samit Hirawat , EVP & Chief Commercial Officer Christopher S. Boerner , and EVP & Corporate Affairs Cari Gallman .

Bristol-Myers Squibb Co (BMY) Insider Trades Summary

Over the past 18 months, Lynch Thomas J. Jr. made no insider transaction in Bristol-Myers Squibb Co (BMY). Other recent insider transactions involving Bristol-Myers Squibb Co (BMY) include a net purchase of 5,071 shares made by Christopher S. Boerner , a net sale of 17,986 shares made by Ann Powell Judge , and a net purchase of 8,500 shares made by Samuels Theodore R. Ii .

In summary, during the past 3 months, insiders sold 700 shares of Bristol-Myers Squibb Co (BMY) in total and bought 1,830 shares, with a net purchase of 1,130 shares. During the past 18 months, 19,418 shares of Bristol-Myers Squibb Co (BMY) were sold and 15,401 shares were bought by its insiders, resulting in a net sale of 4,017 shares.

Bristol-Myers Squibb Co (BMY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Bristol-Myers Squibb Co Insider Transactions

No Available Data

Lynch Thomas J. Jr. Mailing Address

Above is the net worth, insider trading, and ownership report for Lynch Thomas J. Jr.. You might contact Lynch Thomas J. Jr. via mailing address: 800 Howard Avenue, Yale Physicians Building, 2nd Floor, New Haven Ct 06519.